Detalles de la búsqueda
1.
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial.
Braz J Med Biol Res;
57: e13284, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359273
2.
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial
Braz. j. med. biol. res;
57: e13284, fev.2024. tab, graf
Artículo
en Inglés
| LILACS-Express
| ID: biblio-1534074
Resultados
1 -
2
de 2
1
Próxima >
>>